Cancer detection in patients with prostate-specific antigen levels within the grey zone: can synthetic magnetic resonance imaging aid in the differentiation between prostate cancer and noncancerous lesions?

ABSTRACT:

Background

The detection of prostate cancer (PCa) via conventional magnetic resonance imaging (MRI) in patients with prostate-specific antigen (PSA) levels within the grey zone remains challenging. Whether synthetic MRI can provide supplementary benefits for the accurate diagnosis of PCa in this specific population is still unknown. This study aims to investigate the diagnostic performance of synthetic MRI for differentiating PCa lesions from noncancerous lesions in patients with PSA levels within the grey zone (4-10 ng/mL).

Methods

Clinical and MRI data, including synthetic MRI data of patients suspected of having PCa between August 2020 and August 2022, were retrospectively collected from The First Affiliated Hospital of Sun Yat-sen University and Sun Yat-sen University Ca

SUBMITTER: Cao W 

PROVIDER: S-EPMC11651948 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature